A Study on the Progress of Astragalus-Coptis Chinensis Medicinal Pair in the Treatment of Diabetes Mellitus

Author:

Wang Meimei,Su Yanjin

Abstract

According to the relevant studies in recent years, it was found that astragalus - Coptis Chinensis drug pair and its analogous formula have a broad prospect for the treatment of type 2 diabetes mellitus (T2DM). Pharmacological studies have shown that Coptis Chinensis possesses the pharmacological activities of antimicrobial, anti-inflammatory, anti-tumor, lipid regulating, hypoglycemic, anti-arrhythmic, and antioxidant activities[1], and Astragalus possesses the effects of enhancing the function of the immune system, antimyocardial ischemia, bi-directional regulation of blood pressure, anti-tumor, anti-aging, hypoglycemia, and protection of metabolic tissues (liver and kidneys, etc.) [2] [3], the use of Astragalus and Coptis Chinensis pairs has demonstrated significant multiple effects. Specifically, this combination not only effectively reduces blood glucose levels, but also significantly enhances the body's sensitivity to insulin, thus helping to improve the phenomenon of insulin resistance and further enhance the overall health status of patients [1][2][3]. This paper analyzes and researches the research progress of astragalus-Coptis Chinensis medicinal pair and its analogous formulae in the treatment of type 2 diabetes mellitus and the improvement of its complications through the collation and summarization of the literature, in order to lay a certain theoretical research foundation for the clinical diagnosis and treatment of type 2 diabetes mellitus by astragalus-Coptis Chinensis medicinal pair and its related formulae, prevention of diabetes mellitus complications, and rational use of medicines in diabetes mellitus clinical treatment.

Publisher

Century Science Publishing Co

Reference45 articles.

1. Fu Lin, Fu Qiang, Li Ji et al. Research progress on the chemical composition and pharmacological effects of Coptis chinensis[J]. Acta Chinese Medicine and Pharmacology, 2021, 49(02):87-92.

2. Li Bo, Geng Gang. Research progress on the chemical composition and pharmacological effects of Astragalus membranaceus[J]. Research of Integrated Traditional Chinese and Western Medicine, 2022, 14(04):262-264.

3. Chen Guohui, Huang Wenfeng. Progress in pharmacological effects of compositions of Astragalus membranaceus[J]. Chinese Journal of New Drugs, 2008(17):1482-1485.

4. Chen Haozhu, Zhong Nanshan, Lu Zaiying; Ge Junbo, Xu Yongjian, WangChen, editors-in-chief; Tang Chengwei, Xiao Haipeng, Wang Jian'an, Zeng Xiaofeng, deputy editors-in-chief. Internal Medicine 9th edition[M]. Beijing: People's Medical Publishing House, 2022.11

5. 2021 Global Diabetes Map (10th Edition) [EB/OL], 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3